Firm client Goldman, Sachs & Co. noted for its representation of Johnson & Johnson Inc. in its acquisition of Guidant Corp., The Daily Deal,

Firm client Goldman, Sachs & Co. noted for its representation of Johnson & Johnson Inc. in its acquisition of Guidant Corp., The Daily Deal, "J&J Hopes Guidant Will Pump It Up"

According to the December 17th Daily Deal, in an article entitled "J&J Hopes Guidant Will Pump It Up," Johnson & Johnson, "[i]n the biggest deal of its 118-year history...said...it had agreed to buy Guidant Corp. for $25.4 billion in cash and stock. The acquisition of Guidant brings New Brunswick, N.J.-based Johnson & Johnson a strong new line of pacemakers and cardiac defibrillators, devices it previously had not made, as well as Guidant's experimental drug-eluting coronary stents, which are expected to hit the market as early as 2007." [Partners Stuart Katz and Philip Richter represented Goldman Sachs, financial advisers to Johnson & Johnson.]

news-detail.inc